Johannes M. Heuckmann

Gottfried Hagen Str. 20
Koeln, NW 51105, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.

Journal: The Journal of clinical investigation
Published: March 07, 2023

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Journal: Journal of medicinal chemistry
Published: April 29, 2022

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.

Journal: PloS one
Published: April 25, 2021

ALK alterations in salivary gland carcinomas.

ALK alterations in salivary gland carcinomas.

Journal: Virchows Archiv : an international journal of pathology
Published: August 02, 2020

A mechanistic classification of clinical phenotypes in neuroblastoma.

A mechanistic classification of clinical phenotypes in neuroblastoma.

Journal: Science (New York, N.Y.)
Published: March 23, 2018

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 10, 2017

Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.

Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 06, 2017

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2017

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Journal: Cell reports
Published: February 17, 2017

Comprehensive Hybrid Capture-Based Next-Generation Sequencing Identifies a Double ALK Gene Fusion in a Patient Previously Identified to Be False-Negative by FISH.

Comprehensive Hybrid Capture-Based Next-Generation Sequencing Identifies a Double ALK Gene Fusion in a Patient Previously Identified to Be False-Negative by FISH.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 08, 2016

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.

Journal: Science translational medicine
Published: July 21, 2016

ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor.

ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor.

Journal: NPJ precision oncology
Published: June 09, 2016
Showing 1-12 of 30

Last Updated: 09/26/2026